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During the past years, a  number of T  cell antigens defined by conventional 
serology and monoclonal antibodies have become the basis for the distinction of 
T  cell subsets,  especially in  the human, murine, and rat systems (reviewed in 
reference 1). Some of these markers have been directly correlated with T  cell 
functions, either because they are only expressed on a given functional subset or 
because antibodies to them block or stimulate certain T  cell reactions. A  well 
studied example is the murine Lyt-2 (human OKT8/Leu-2) antigen. Originally 
thought to be a  marker for cytotoxic (and suppressor) T  cells (2),  more recent 
data suggest an association of this antigen with T cell recognition of class I major 
histocompatibility complex (MHC) 1 antigens rather than with cytolytic function 
(3). Thus, Class I-specific helper T  cells were found to be Lyt-2  + as well (4), and 
conversely, class II specific cytolytic T  lymphocytes (CTL) with little or no Lyt- 
2 antigen were described (5).  In the human, an analogous antigen is known to 
be associated with the recognition of class  II MHC antigens (OKT4/Leu-3) (6, 
7),  and its likely murine counterpart (L3T4)  has been described recently (8). 
The  strongest  evidence  for  an  involvement  of the  molecules bearing  these 
antigens in the recognition of MHC restriction elements is the capacity of anti- 
Lyt-2  (3)  and anti-L3T4  (8) antibodies (and their counterparts in  the human 
system [9]) to block the activities of cytotoxic and helper T  cells that recognize 
class I and class II antigens, respectively. Accordingly, it has been proposed that 
the T  cell structures defined by  these antibodies interact with  monomorphic 
determinants  on  MHC  molecules,  thereby  providing  an  MHC  class-specific 
recognition step in addition to the T  cell receptors' interaction with its target 
antigen (3). 
Recently,  evidence has  been  presented  suggesting  that  the  mechanism by 
which lectins polyclonally activate T  cells (10) and mediate nonspecific (CTL)- 
lysis (1 1) (lectin-dependent cellular cytotoxicity, LDCC) is similar or identical to 
that operating in antigen-specific systems. Thus, it has been postulated that T 
ceils recognize lectin-modified MHC antigens on  "accessory" and target  cells. 
The finding that LDCC (12) and lectin-induced reactivity to interleukin 2 (IL-2) 
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(13) can be blocked with  monoclonal anti-Lyt-2 has been interpreted as a  key 
result supporting this hypothesis (14). On the other hand, H-2-negative cells can 
serve as targets in LDCC (15) and as accessory cells in polyclonal T  cell activation. 2 
In the present report, the hypothesis that anti-Lyt-2 blocks at the level of MHC 
class recognition was tested by examining its capacity to inhibit LDCC of H-2- 
positive and H-2-negative target cells. 
Materials and Methods 
Mice.  Balb.K (H-2  k, Lyt-2.2), CBA/J (H-2  k, Lyt-2.1), and BALB/c (H-2  d, Lyt-2.2) mice 
were bred in our colony and used at 2-6 months of age. 
Generation ofCytotoxic Effector Cells.  Spleen cells were cultured in RPMI  1640 supple- 
mented as given in reference 16. They were either stimulated for 3 d with concanavalin 
A  (Con A) (2  ~g/ml) at 2 ×  106/ml  in 2-ml cultures seeded into 24-well  tissue culture 
plates (Costar, Data Packaging, Cambridge, MA), or for 5 d with irradiated (2,000 rads 
from a 6°Co source) allogeneic spleen cells as described (16).  Con A-induced CTL were 
incubated with 50 mM a-methyl-mannoside for 15 min, followed by two washes,  before 
the CTL assay. 
Target Cells.  The C58/J (H-2  k, Lyt-2.1) thymoma R 1.1 and the t32-microglobulin (and 
therefore H-2  k) negative variant R1E/TL8x. 1 (for short, R1.E), which were derived and 
characterized by Hyman and  Stallings (17),  were kindly provided by Dr.  K.  Fischer- 
Lindahi (Basel Institute for Immunology). They were labeled with 100 ~Ci S~Cr-Na~CrO4 
in 0.5 ml BSS/BSA in the presence or in the absence of 5 #g Con A, followed by two 
washes. 
Antibodies.  The hybridoma 19/1782c producing anti-Lyt-2.2 antibody of the IgG2a 
subclass was kindly provided by Dr. G. Hfimmerling  (DKFZ, Heidelberg, FRG). IgG was 
prepared from ascitic fluid by ammonium sulfate precipitation and fractionation on an 
Affigel blue column (Biorad Laboratories GmbH, Mfincben, FRG). As judged by protein 
staining of SDS-PAGE, the recovered material contained almost exclusively IgG. Anti 
LFA-I (18), the kind gift of Dr. M. Pierres (Centre D'Immunologie de Marseille-Lfiminy), 
was used in the form of culture supernatant (hybridoma clone H 35-89.9 rat ~'2b). 
CTL Assay (16).  The cytotoxic effector cells were preincubated with the monoclonal 
antibodies in a total volume of 0.5 ml supplemented (16) RPMI for 30 min at 4°C in 120 
mm ×  7.5 mm polystyrene tubes. 4  ×  104 target cells were added in another 0.5 ml of 
medium, and the mixture was incubated for 4 h at 37°C in an atmosphere containing 5% 
CO2 in air. After mixing and centrifugation at 2,000 rpm for 5 min, 0.5-ml samples of 
the supernatants were counted. Specific lysis was calculated according to the formula: 
experimental release -  spontaneous release 
% specific lysis =  100 ×  detergent release -  spontaneous release 
Results 
Btockb~g of Specie and Lecti~-d@endent  Lympholysis Mediated  by Atloreactive CTL 
with  Monoclo~ml Anti-Lyt-2.2  Antibody.  Fig.  1  shows  an  experiment  in  which 
BALB/c anti-Baib.K  (H-2  d anti-H-2 k)  CTL  were tested against  the C58/J  thy- 
moma R1.1  (H-2  k) and the ~2-microglobulin defective and therefore H-2  k nega- 
tive variant,  R1.E.  As expected, only the  H-2k-positive target cells were lysed 
(Fig.  1 A).  However, pretreatment with  Con  A  rendered R1.E cells susceptible 
to lysis as well (Fig.  1 C).  This is in agreement with results of Bevan and Hyman 
(15),  who  first  described  LDCC  of H-2-negative cells.  Inclusion  of  10  tag/ml 
purified anti-Lyt-2.2 antibody markedly reduced both the antigen-specific (Fig. 
Hfinig, T. 1983. The role of accessory cells in polyclonal T cell activation, lII. No requirement 
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FIGURE  1.  Antigen-specific lysis of H-2  + and LDCC of H-2- target cells by alloreactive CTL 
is inhibited by anti-Lyt-2.2. BALB/c (H-2  d) anti-Balb.K (H-2  k) CTL were tested against R 1.1 
(H-2  k) (A, A), R.  1  .E (H-2-) (1"1), and Con A-pulsed R  1  .E (O, 0) target cells in the presence 
(A, O) or in the absence (A, O) of purified anti-Lyt-2.2. (A, C) Titration of effector cells _.+ 10 
#g/ml anti-Lyt-2.2. (B, D) Titration of anti-Lyt-2.2 at a constant effector/target ratio of 20:1. 
Spontaneous release varied from 14.4 to 25.8%. 
1A)  lysis  of H-2 k positive  and  LDCC  of H-2-negative  target  cells  (Fig.  1 C). 
Titration of the antibody at a  constant effector/target ratio (Fig.  1, B and D) 
indicated that similar antibody concentrations were required for inhibition  in 
both systems. 
Blocking of LDCC Mediated  by Polyclonally Induced  CTL with Anti-Lyt-2.2  and 
Anti-LFA-I.  In the experiment shown in Fig. 2, Con A-pulsed R  1.1 (Fig. 2, A 
and B) and R  1.E (Fig.  2,  C and D) cells were used as targets for polyclonally 
(Con A-) induced CTL. LDCC of the H-2-negative target was less than that of 
the H-2-positive parent line (note the different scale), but was significant and 
reproducible. As can be seen, monoclonal anti-Lyt-2.2 inhibited lysis of both 
targets.  In  addition,  culture supernatants from a  hybridoma producing anti- 
LFA-1 antibody were inhibitory in both systems. Unlike Lyt-2, LFA-1 expression 
is  not correlated with  class  I  or class  II  MHC recognition (8).  Again,  similar 554  ANTI-LYT-2 IN  LDCC 
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FIGURE 2.  Inhibition of LDCC of H-2  + and H-2- target cells by anti-Lyt-2.2 and anti-LFA- 
1. Con A-induced CTL from Balb.K mice were tested against R 1.1 (A), R 1.E (ff]), and Con 
A-pulsed R 1.1 (~7, 0, ") and R 1  .E (O, O, I) target cells in the absence of inhibiting antibodies 
(XT, O), or in the presence of anti-Lyt-2.2  (V, O), or of anti-LFA-I (0, I). (A, C) Titration of 
effector cells +20 ~g/ml anti-Lyt-2.2 or anti-LFA-1 at 1:20 final. (B, D) Titration of inhibitory 
antibodies at a constant effector to target ratio of 30:1. Spontaneous  release varied from 12.9 
to 29.9%. 
titration  curves were obtained  for these antibodies  in the blocking of LDCC of 
H-2-positive and H-2-negative target cells. While the blocking of LDCC of both 
types of target cells with anti-Lyt-2.2 and anti-LFA-1  was a  consistent finding, 
the relative efficiency with which the two antibodies inhibited was variable from 
experiment  to  experiment.  The  allele  specificity  of blocking with  monoclonal 
anti-Lyt-2.2  antibody is shown in Table  I.  Lysis of Con A-pulsed  R  1.1  and R 
I.E target  cells by Balb.K  (Lyt-2.2) but not by CBA (Lyt-2.1) Con A-activated HLINIG 
TABLE  I 
Monoclonal Anti-Lyt-2.2 Inhibits LDCC of H-2 + and H-2- Target Cells in 
a n Allele-specific Ma nner 
555 
% specific 
Effector  Lyt-2 al-  Target cell  Antibody added*  51Cr re- 
cells*  lele  lease 
Balb.K  2.2  R  1.1  --  0.2 
Balb.K  R  1.1-Con A  --  56.5 
Balb.K  R  1.1-Con A  Anti-Lyt-2.2  34.4 
Balb.K  R  1.1-Con A  Anti-LFA-1  24.8 
Balb.K  R  1.E  --  -0.1 
Balb.K  R  l.E-Con A  --  20.0 
Balb.K  R  1 .E-Con A  Anti-Lyt-2.2  10.1 
Balb.K  R  1.E-Con A  Anti-LFA-1  8.1 
CBA  2.1  R  1.1  --  1.3 
CBA  R  1.1-Con A  --  51.5 
CBA  R  1.1-Con A  Anti-Lyt-2.2  48.3 
CBA  R  l.l-Con A  Anti-LFA-1  22.9 
CBA  R  I.E  --  1.2 
CBA  R  1.E-Con A  --  22.8 
CBA  R  l.E-Con A  Anti-Lyt-2.2  22.4 
CBA  R  1.E-Con A  Anti-LFA-1  10.0 
* Con A-activated spleen cells. Effector/target ratio 60:1. 
* Anti-Lyt-2.2:10 ug/ml final; anti-LFA-1:1:20 dilution of culture supernatant. 
CTL was blocked. In contrast, anti-LFA-1, a rat antibody reactive with LFA-1 
on  the  cells of all  mouse strains,  was  inhibitory  for effector ceils from both 
strains. 
Discussion 
The experiments presented here show that monoclonal anti-Lyt-2 antibodies 
can block  LDCC  of H-2-negative target cells.  The  minimal conclusion to be 
drawn is that in LDCC, blocking with anti-Lyt-2 antibodies cannot be taken as 
evidence for the recognition of class I H-2 antigens in LDCC. Unless two distinct 
mechanisms by which anti-Lyt-2 blocks T  cell-mediated cytotoxicity are to be 
postulated, this conclusion can be extrapolated to antigen-specific T  cell killing 
as well. 
Basically,  two  functions  have  been  suggested  for  the  Lyt-2  bearing  T-cell 
surface molecule: strengthening of adhesion between CTL and target cell (12, 
20),  and  recognition  of class  I  MHC  antigens  (3).  Both  proposals  take  into 
account that inhibition of cytolysis by anti-Lyt-2 antibodies operates at the level 
of CTL-target  cell conjugate formation (21).  The finding that antibodies  to 
LFA-1 (18) interfere with the same step in T cell-mediated target cell destruction 
(20) seems to put Lyt-2 and LFA-1  into the same category. Unlike blocking by 
anti-LFA-1, however, which affects T  cells recognizing H-2 class  I and class  II 
antigens, sensitivity to inhibition by anti-Lyt-2 is considered a property of only 
class I-specific T  cells (3). The idea that the Lyt-2-bearing molecule is itself the 
T  cell receptor had to be discarded with the discovery ofcodominant expression 556  ANTI-LYT-2 IN  LDCC 
of both  Lyt-2 alleles on the same cell (22).  Instead, it has been proposed that 
Lyt-2 is part of the T  cell receptor complex, where it functions as a MHC class- 
specific  receptor  by  interacting  with  monomorphic  determinants  on  class  I 
molecules (3).  Exceptions have,  however, been  found to  the rule  that  class  I 
MHC recognition is associated with Lyt-2 expression (23, 24), and some Lyt-2  + 
CTL are resistant to blocking with anti-Lyt-2 antibodies (25).  In view of these 
findings, the involvement of the Lyt-2 antigen in the adhesion of class I-specific 
T  cells to their targets has more cautiously been interpreted as a  "stabilizing" 
effect that is required only in low affinity interactions of the T  cell receptor with 
class I antigens (25). 
According to the data presented here, sensitivity to blocking with anti-Lyt-2 
can not be regarded as evidence for the recognition of class  I  MHC antigens. 
On the other hand, the predominant expression of Lyt-2 on class I-specific T  cells 
remains suggestive of its involvement in the T  cell receptor complex. Thus, it 
could be envisaged that even in LDCC of H-2-negative target cells, participation 
of the T  cell receptor complex is required. If the Lyt-2 antigen is part of that 
complex, blocking of both LDCC and antigen-specific killing may proceed by a 
mechanism distinct from interfering with the postulated interaction of the Lyt- 
2-bearing structure with monomorphic class I determinants. 
A  result possibly analogous to  the one reported here about anti-Lyt-2 was 
recently published for the monoclonal antibody against L3T4, the presumptive 
murine analogue to the human T4 antigen, which is found associated with class 
II recognition (8). This antibody was selected in a screening assay in which LDCC 
of P815  (i. e. class  II negative!) target cells by a  T  cell clone of unknown (but 
presumably class II restricted) specificity was blocked. 
Finally, the blocking of LDCC  of H-2-negative target cells with anti-Lyt-2 
indicates that CTL, and not natural killer (NK) cells, are the effector cells in this 
system. This supports the notion that T  cell reactivities mediated by lectins need 
not involve MHC antigens on target (or "accessory") cells (15). 2 
Summary 
The  hypothesis  that  blocking  of cytotoxic T  lymphocyte (CTL)-mediated 
cytolysis with anti-Lyt-2 antibodies acts at the level of inhibiting the interaction 
of the Lyt-2-bearing structure with H-2 class  I molecules was tested. In agree- 
ment with the findings of others, purified anti-Lyt-2.2 inhibited both antigen- 
specific lysis and lectin-dependent cellular cytotoxicity (LDCC).  LDCC of H-2- 
positive and H-2-negative target cells was similarly inhibited by this antibody. 
As expected, this effect was specific for CTL expressing the Lyt-2.2 allele, in 
contrast to blocking with a rat monoclonal antibody to the murine LFA-1 antigen. 
The implications of this finding for the function of the Lyt-2 antigen in CTL- 
target cell interaction are discussed. 
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